Novel Circumplast Device for Enhanced Safety in Paediatric Male Circumcision in Pakistan at the 31st Annual Conference of the Association of Paediatric Surgeons of Pakistan

Dr A R Khan Introduced a novel Circumplast Device for Enhanced Safety in Paediatric Male Circumcision in Pakistan at the 31st Annual Conference of the Association of Paediatric Surgeons of Pakistan.

Introduction:

In the dynamic landscape of paediatric surgery, advancements prioritising safety and efficacy are pivotal. The 31st Annual Conference of the Association of Paediatric Surgeons of Pakistan (APSP) witnessed a groundbreaking development as Dr A R Khan unveiled the Circumplast device, which is designed to augment the safety and precision of male infant circumcisions. Attended by 280 Paediatric surgeons, the event marked a substantial progression in Paediatric surgical techniques.

Dr. A R Khan's Pioneering Contribution:

With a three-decade tenure in Paediatric surgery, Dr A R Khan has consistently contributed to refining surgical methodologies, emphasising the safety and well-being of young patients. His extensive experience and commitment to progressive approaches have earned him respect in Pakistani Paediatric surgery.

The Circumplast Device for Paediatric Male Circumcision:

The focal point of the conference was the introduction of Dr. Khan's innovative Circumplast device. This sophisticated apparatus is engineered to elevate the safety and precision standards in Paediatric male circumcisions, a routine procedure performed for cultural, religious, or medical reasons. Dr. Khan's device seeks to streamline the process while mitigating potential risks and complications associated with Paediatric circumcision.

Key Features of Circumplast:

1.     Safety Emphasis: The Circumplast device prioritizes safety by minimising the risk of complications, particularly migration to the penile shaft, a concern observed with alternative devices such as Plastibell.

2.     Precision and Consistency: Ensuring meticulous removal of the foreskin, the Circumplast device guarantees precision and consistency—a critical aspect in circumventing potential complications like preputial adhesions.

3.     Procedure Time Optimization: Dr. Khan's device optimises the circumcision process, reducing procedural durations. This benefits the Paediatric patient and enhances operational efficiency in healthcare settings.

4.     Discomfort Mitigation: Acknowledging the inherent anxiety and discomfort experienced by Paediatric patients, the Circumplast device is meticulously designed to minimize such sensations, fostering a more tolerable experience for young recipients.

31st APSP International Conference:

The conference was an ideal platform for Dr  A R Khan to disseminate information regarding his groundbreaking invention among the Paediatric surgery community. Attended by 280 Paediatric surgeons from Pakistan and abroad, the event facilitated the exchange of knowledge, ideas, and advancements in the field.

Dr Khan's presentation captivated the audience, featuring a live demonstration of the Circumplast device and an in-depth discussion of its potential impact on the future landscape of Paediatric surgery. The ensuing interactive session allowed surgeons to pose questions, share insights, and engage in meaningful discourse about this innovative device.

Conclusion:

Dr. A R Khan's presentation at the 31st APSP International Conference signifies a noteworthy advancement in Paediatric surgery. The introduction of the Circumplast device not only underscores Dr Khan's dedication to innovation but also highlights the collaborative efforts crucial for advancing healthcare practices. As the medical community embraces this pioneering technology, the future of Paediatric surgery appears promising, with an enhanced focus on safety and patient-centric approaches through the utilization of Circumplast devices for secure Paediatric male circumcisions.

Contact the Executive Manager for further information and Circumplast order in Pakistan +92 308 5492563

RE-AUDIT OF EARLY COMPLICATION ESPECIALLY IMPACTION OF DISPOSABLE DEVICE: IMPROVING OUTCOMES OF CIRCUMCISIONS WITH PLASTIBELL AND CIRCUMPLAST RINGS IN CHILDREN IN A COMMUNITY CLINIC

AIM: To evaluate the early postoperative complications particularly impaction of disposable devices ( Plastibell and Circumplast ) in children’s circumcision procedures under local anaesthesia between different age groups, size and types of rings, and different doctors in a community clinic.
MATERIAL AND METHODS
In our re-audit, the outcome of circumcisions (n=1449) was studied over a 1 year period (May 2016 to April 2017) performed under local anaesthesia, by trained doctors in a community clinic doing Circumplast Circumcisions (CC) (n=470) and Plastibell circumcisions (PC) (n=979). Data was collected prospectively and early postoperative complications especially ring impaction were compared between age of the child, size and types of device, and doctors who have performed the circumcision. Follow-up was arranged if required.
RESULTS
The mean age was 6.5±0.4 months (median 1.6). Overall complication rate was 6.7% (97/1449). There is no significant difference in overall complications rate in CC (7% n=33/470) versus PC (6.5% n=64/979) (p>0.5). Although ring impaction is significantly lower in Circumplast circumcision  (0.4% n=2/470) versus Plastibell circumcision (3.4% n=33/979) (p<0.05) but it has significantly improved from the previous audit (CC 3.2% n=7/208 versus PC 8.7% n=102/1179 – ESPU 2016). There is significantly lower incidence in ring impaction with Plastibell size 1.4 as compared to 1.3, 1.5 and 1.7. There is no impaction in 1.1 and 1.2 sizes. Ring impaction was significantly lower in infants versus over 1 year child (1.5% vs 10% n= 19/1280 vs 17/169, p<0.5) respectively. There is no significant difference in complications (8.5%, 7.1%, 6.5%, 5.8% and 5%) among the five doctors’ cases (p>0.5). Mean follow-up for 354 (24%) children were 14 days (median 6).
CONCLUSIONS
This concludes that no significant difference noted in overall early complications of circumcisions between age of the child, size and types of device used, and among different doctors. However, ring impaction was significantly lower in infants, Plastibell size 1.4 and Circumplast.

Accepted as a poster and presentation in ESPU 2018. This abstract is published at https://congress2018.espu.org/

All children operated at Thornhill clinic, Luton, Leyton Clinic, London and Croydon Clinic, London

Doctor is using the Circumplast device for children circumcision at Uddevalla, Sweden

Doctor from Sweden was trained at London for the Circumplast circumcision and has started to use Circumplast circumcision device for the  children at his centre. 

He was very impressed with the results of the Circumplast circumcision and design of Circumplast device. 

Outcome of Circumplast and Plastibell at Thornhill Circumcision Centre

This cohort study will evaluate the early postoperative complications in Circumplast and Plastibell techniques, in a community clinic- Thornhill Circumcision Centre, for non-therapeutic male circumcision.

We reviewed the outcome of non-therapeutic male circumcision in children (n=1387) over a 1 year period (May 2014 to April 2015) in a community clinic - Thornhill clinic , performed under local anaesthesia, by trained doctors with the backup of a trained paediatric surgeon (figure 1-4). The technique was selected by doctors’ preference. Data was collected prospectively and early postoperative complications were compared between Circumplast and Plastibell circumcisions. Follow-up consultations were arranged if required.

The mean age was 18 ± 1.9 months (median 5.1) in Circumplast circumcision (CC) and 9.4 ± 0.6 months (median 1.5) in Plastibell circumcision (PC). Incidence of complications is significantly lower in CC (6.3% n=13/208) versus PC (13% n=154/1179) (p<0.05) (complications graph). Postoperative use of antibiotics was higher in CC versus PC (6.7% vs 3.8% n=14 vs 45) but not statistically significant (P>0.05). Mean follow-up consultations were 19 days (range 1 to 373) in CC and 20 days (range 1 to 305) in PC.

Outcome

Non-therapeutic male circumcision by the Circumplast device has a significantly lower risk of early postoperative complications in a community clinic, especially migration/impaction of the ring when compared to the standard Plastibell device.

Circumplast device size

Circumplast device are available in four different sizes (9.5, 11, 12, and 13) which is equivalent to Plastibell sizes 1.2, 1.3, 1.4 and 1.5. Boxes and individual items are colour coded with green (size 9.5), red (size 11), orange (size 12) and dark blue (size 13).